International Business Machines Corporation
IBMInternational Business Machines Corporation's earnings have outrun its stock. EPS grew +73.7% in a year against a −6.0% price move.
The sharpest disagreement: annual EPS moved +73.7% against a −6.0% price move — the market has not yet caught up with the delivery.
The price is in a downtrend (1 weeks in) while the P/E sits at the 10th percentile of its own 4-year range. Underneath, the last four quarters read improving — profit +16.2% year on year, and 168% of the last 3 years' profit arrived as cash. What settles it: whether the price catches up with earnings that have already moved.
Price story Before the numbers, the tape. A stock price moves through four repeating seasons: a flat base (stage 1), an advance (2), a top (3), a decline (4). Where the price sits in that cycle frames everything below.
International Business Machines Corporation trades at $235, in a downtrend and 1 weeks into that stage. That is −12.9% against its own 200-day average. It sits at 23% of a 52-week range of $213 to $309. On relative strength it is currently behind the S&P 500 on a trailing-13-week view (4 weeks and counting).
Today the stock is in a downtrend — week 1 of stage 4. At $235 it trades −12.9% versus its 200-day average and sits at 23% of its 52-week range ($213–$309).
Against the market, two honest reads. Cumulative: over the last 10.1 years the stock moved +59% while the S&P 500 moved +263% — behind the index over the full window. Recent form: on a trailing-13-week view the stock is currently behind (4 weeks and counting; last ahead the week of 2026-07-10) — the ribbon below is that same metric, week by week.
What would end the trend, mechanically: two Friday closes in a row below the 200-day line. That is the exit rule — no debates.
Valuation P/E is the price of $1 of annual profit: how many dollars the market pays for each dollar the company earns in a year.
International Business Machines Corporation trades at 20.1× P/E, near the bottom of its own range — cheaper only 10% of the time. Its long-run median P/E is 31.7×, measured across 4.3 years of weekly readings. This places the multiple against the stock’s own record, and says nothing about what the business is worth.
Today's P/E of 20.1× is near the bottom of its own range — cheaper only 10% of the time, against a long-run median of 31.7× measured over 4.3 years of weekly readings. This is a comparison against the stock's own history — not a claim about what it is worth.
One caveat before moving on: margins are the best this company has ever printed — cheap against its own history on record margins is not the same thing as cheap. If profitability mean-reverts, today's multiple is higher than it looks.
Why the multiple sits where it does: over the past year annual EPS moved +73.7% against a −6.0% price move — earnings outran the price, pushing the multiple DOWN its own range.
The price move, decomposed: over 3y, of the +17.7%/yr price move, ~+73.9%/yr came from earnings growth and ~−56.2 pp from the multiple (compressing). The split is the honest approximate (price return minus earnings growth); it makes the rally itself visible instead of hiding it behind the percentile.
Put together: the multiple is low against its own past, so the story rests on the earnings line underneath it, not the multiple.
Stage: Mixed Every business sits somewhere on a fundamental arc, and this page names the spot before anything else. The last twelve quarters of revenue, profit and EPS growth — plus the return the business earns on its capital — are read as curves: Deteriorating (the curves are falling), Turning around (a trough has just formed and the last few quarters lift off it), Improving (the climb off the trough is sustained), Consistent (steadily positive with healthy returns), Topping out (still high but decelerating from the peak). When the curves genuinely disagree the read is Mixed; too little history is No read. CAGR (compound annual growth rate) is the smooth yearly pace that turns the starting value into the latest one — the fairest way to compare growth across different time spans. Read the columns together: if the 1-year number towers over the 10-year, recent growth is running hotter than the long-run trend. A dash means that window is not held, or the base year was a loss (where a growth rate is not meaningful).
International Business Machines Corporation reads as mixed on its fundamental arc. Mixed — the growth curves are steadily positive, but ROCE at 10.5% is below the 15% bar this page requires to call it Consistent. The read is built from 12 quarters across 4 curves, on full evidence.
Why it matters: when the curves disagree, the per-curve reads above matter more than any single verdict.
| 1yr | 3yr | 5yr | 10yr | |
|---|---|---|---|---|
| Revenue | +7.6% | +3.7% | — | — |
| Profit | +75.9% | +81.1% | — | — |
| EPS | +73.7% | +83.8% | — | — |
| Stock price | −6.0% | +17.7% | +11.3% | +4.2% |
4-Factor Sector Score
40.3/100 — rank 18 of 27 in Information Technology Services · 58% evidence confidence
International Business Machines Corporation scores 40.3 out of 100 against the 27 companies it is compared with in Information Technology Services, ranking 18. Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
The four contributions add to the total exactly: 16.4 + 9.8 + 9 + 5.1 = 40.3. This is the SAME number shown on the sector comparison — it is computed once, for the whole peer set, and read here.
What would change it: The read weakens if profit growth turns negative or margin improvement reverses while sector-relative strength deteriorates.
Revenue Revenue is the top line: everything the company billed its customers in the period.
International Business Machines Corporation reported $15.9 B of revenue in the Mar 26 quarter, +9.5% year on year. That is the 8th straight quarter of year-on-year growth. Over 4 years it has compounded at 4.2% a year. The last full year, FY25, came in at $67.5 B. The last four reported quarters add to $68.9 B.
FY25 revenue came in at $67.5 B (+7.6% on the year), capping 4 years at 4.2% compound. The latest quarter (Mar 26) printed $15.9 B, +9.5% year on year — the 8th consecutive quarter of year-over-year growth.
Pace check: the last four quarters averaged +9.6% growth against the decade's 4.2% — the current year is running faster than its own long-run rate.
Acceleration check: trailing-twelve-month revenue grew +9.7% over the last 4 quarters against +5.4%/yr over the last 8 — accelerating; TTM profit +95.4% vs +14.7%/yr — accelerating.
Operating margin Operating margin is what is left of every $100 of sales after running the business, before interest and tax. It is the cleanest read on pricing power and cost control.
International Business Machines Corporation's operating margin is 11.7% in the Mar 26 quarter, +0.6 percentage points against the same quarter a year ago. That is the widest this company has ever printed on a full-year basis. Across 5 fiscal years the operating margin has ranged 3.9% to 18.2%. The current quarter sits inside that band.
The latest quarter's operating margin is 11.7%, +0.6 pp against the same quarter a year ago. Across 5 fiscal years the operating margin has ranged 3.9%–18.2%, and FY25's 18.2% is the top of that band — a record year.
Why the margin moved: operating margin went +0.6 pp year on year while gross margin went +1.0 pp — the gain came mostly from the gross line: input costs and pricing.
Worth repeating from the valuation section: cheap against its own history on record margins is not the same thing as cheap — a record margin flatters every ratio built on top of it.
Net profit Net profit is what survives every cost, interest and tax — the number EPS, dividends and book value all grow from.
International Business Machines Corporation earned $1.2 B of net profit in the Mar 26 quarter, +16.2% year on year. It is the 2nd consecutive quarter of growth. Full-year FY25 profit was $10.6 B. The 4-year compound rate is 22.4%. That is 7.7% of the quarter's revenue. The same quarter a year earlier earned $1.1 B.
Mar 26 profit was $1.2 B, +16.2% year on year — the 2nd consecutive quarter of growth. On the full year, FY25 printed $10.6 B (+75.9%), and the 4-year compound rate is 22.4%.
Why profit moved: revenue contributed +9.5% and the margin +0.6 pp — the quarter was revenue-led, with the margin roughly flat.
Pace comparison, last four quarters: profit +42.1% vs revenue +9.6%. Profit is growing faster than sales — fixed costs are being spread over a bigger base, and each extra dollar of revenue drops more to the bottom line.
Cash flow — the router The P&L says what was earned; the cash-flow statement says what actually arrived. Operating cash flow (CFO) against profit is the cleanest lie detector in the accounts.
Over the last 3 fiscal years 168% of International Business Machines Corporation's reported profit arrived as operating cash — the cash follows the profit. In FY25 that was $13.2 B of operating cash against $10.6 B of profit. After $1.1 B of capital spending, $12.1 B was left as free cash.
FY25: operating cash of $13.2 B against reported profit of $10.6 B, leaving free cash of $12.1 B after $1.1 B of capital spending. Across the last 3 fiscal years the conversion rate is 168% of profit.
Cash-flow readings here are annual — that is the resolution our series carries, so this section moves once a year.
Why: conversion is measured cleanly, but the working-capital day-counts behind it sit below what we hold — the move is shown without inventing its driver.
Router verdict: the visible cash user is investment — the next section checks what the spending is buying.
Where the cash goes Working capital is the cash tied up between paying suppliers and getting paid: debtor days (customers owe), inventory days (stock waits), and the cash conversion cycle (the whole loop, in days of sales).
International Business Machines Corporation does not report the debtor, inventory and payable day-counts a cash cycle is built from, so this section reads the investment side instead. Capital spending ran $3.0 B over the last 3 years. Averaged over those years that is 1.5% of FY25 revenue a year.
Working-capital day-counts are not in our numbers for this stock, so this section reads the investment side — where the cash is being put to work.
On the investment side: capital spending of $3.0 B over the last 3 fiscal years.
The synthesis: the cash is going into capacity, not disappearing into the cycle — the question becomes whether the new capacity earns.
Return on equity Return on equity (ROE) is the profit the business earns on its shareholders’ money. With the full capital-employed split not in our numbers, ROE is the cleanest long ladder we can draw here.
International Business Machines Corporation earns a ROE of 32% in FY25. That is up from a trough of 8% in FY22. Return on invested capital clears the cost of that capital by +7.1 percentage points, so growth here adds value rather than only size. The wiring behind it is 15.7% net margin on 0.44× asset turns.
FY25 ROE is 32%, recovered from a FY22 trough of 8% — the full ladder below shows the fall and the climb, undoctored.
Why the return is what it is — the wiring (FY25): 15.7% net margin × 0.44× asset turns × 4.64× balance-sheet leverage ≈ 32.1% on equity. Margin is doing the heavy lifting; leverage is a meaningful part of the equation.
The capstone test — ROIC − WACC: 14.0% − 6.9% = a +7.1 pp spread. The 6.9% is an estimate of this company's own cost of capital — read the sign and the size of the spread, not the decimals. A spread this wide means every dollar reinvested creates more than a dollar of value — the engine compounds.
Dividend A dividend is cash paid out per share. Dividend per share is the declared amount for the period; the trailing twelve-month total is the four most recent quarters added together.
International Business Machines Corporation paid $6.72 per share over the last four reported quarters, up 0.6% on a year ago. The most recent declaration was $1.68 for Mar 26. Against the current price of $235 that is a trailing yield of 2.86%, measured on dividends already paid rather than on a forecast.
International Business Machines Corporation paid $6.72 per share across the last four reported quarters, most recently $1.68 for Mar 26. That is up 0.6% against the same quarter a year earlier. Against the current price of $235 the trailing twelve months work out to 2.86% — trailing dividends measured against today's price, not a forward estimate.
Debt Debt-to-equity says how much of the business is funded by borrowings. Low is the safe corner; the trend matters as much as the level.
International Business Machines Corporation carries total debt of $65.3 B against shareholder equity of $34.5 B as of Jun 26, a debt-to-equity of 1.89. On the annual view that ratio went from 2.90 in FY21 to 1.97 in FY25. Read the returns elsewhere on this page with that leverage in mind.
Jun 26: total debt of $65.3 B against shareholder equity of $34.5 B — a debt-to-equity of 1.89. On the annual view, debt-to-equity went from 2.90 (FY21) to 1.97 (FY25). Read the returns on this page with that leverage in mind.
Ownership There is no quarter-by-quarter holder register to read here, so we read the crowd through short interest — the slice of tradable shares currently sold short, positioned for a fall.
3.5% of International Business Machines Corporation's tradable float is currently sold short — some money is positioned against it. At typical trading volumes those positions would take about 2.8 days to buy back. There is no quarter-by-quarter holder register to read for this filer, so the crowd is read through short interest instead.
The latest reading: 3.5% of the float is sold short, and at typical trading volumes it would take about 2.8 days to buy those positions back. Some money is positioned against it. This is a single point-in-time reading — we do not yet hold its history, so we show no trend chart.
Why it sits there: who is doing the shorting, and why, does not travel with the number — the level is shown without inventing its story.
Safety line The Z-score estimates how far a company sits from balance-sheet distress — above roughly 3 is safe, below roughly 1.8 is the danger zone. It was built for manufacturers, so it is not applied to banks and lenders.
International Business Machines Corporation: the Z-score reads 3.40. A Z-score above roughly 3 reads as safe and below roughly 1.8 as the distress zone, so this sits well clear of distress. It is a distance-to-distress estimate from the balance sheet, not a forecast of failure.
Why it matters: a Z-score of 3.40 sits well clear of the distress zone — the balance sheet is not the risk here.
The safety line in one sentence: the Z-score reads 3.40.
| Company | Score | Price stage | Growth & earnings/35 | Capital efficiency/25 | Valuation/20 | Relative strength/20 |
|---|---|---|---|---|---|---|
| 1Science Applications International CorporationSAIC | 67.6/100Favorable setup85% evidence | BREAKING OUT | 21.5/35 Revenue -2.9% · PAT 14.7% · OPM change 3 pp 95% evidence | 12.6/25 ROCE 4.5% · OPM 9.4% 76% evidence | 15.7/20 P/E 10.8× · PEG 0.44 65% evidence | 17.8/20 RS sector 8.2% · RS bench 6% · 1Y 3.2%7 of 12 weeks ahead 100% evidence |
| Exact sum: 21.5 + 12.6 + 15.7 + 17.8 = 67.6 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 2Jack Henry & Associates, Inc.JKHY | 59.6/100Mixed-positive evidence81% evidence | TURNING | 21.6/35 Revenue 8.4% · PAT 21.2% · OPM change 0.7 pp 83% evidence | 16.1/25 ROCE 6% · OPM 24.4% 76% evidence | 11.7/20 P/E 22.1× · PEG 1.01 65% evidence | 10.2/20 RS sector -9.5% · RS bench -11.8% · 1Y -3.1%0 of 12 weeks ahead 100% evidence |
| Exact sum: 21.6 + 16.1 + 11.7 + 10.2 = 59.6 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 3Broadridge Financial Solutions, Inc.BR | 58.8/100Mixed-positive evidence81% evidence | TURNING | 20.4/35 Revenue 8.2% · PAT 39.6% · OPM change -0.6 pp 83% evidence | 15.4/25 ROCE 5.2% · OPM 18.4% 76% evidence | 14.8/20 P/E 17.4× · PEG 0.43 65% evidence | 8.2/20 RS sector -20.2% · RS bench -22.8% · 1Y -36.7%1 of 12 weeks ahead 100% evidence |
| Exact sum: 20.4 + 15.4 + 14.8 + 8.2 = 58.8 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 4Gartner, Inc.IT | 57.8/100Mixed-positive evidence81% evidence | TURNING | 16.2/35 Revenue 2.3% · PAT -41% · OPM change 2.8 pp 83% evidence | 16.9/25 ROCE 7.5% · OPM 20.9% 76% evidence | 14.3/20 P/E 15.6× · PEG 0.45 65% evidence | 10.4/20 RS sector -12.3% · RS bench -15.3% · 1Y -18.9%1 of 12 weeks ahead 100% evidence |
| Exact sum: 16.2 + 16.9 + 14.3 + 10.4 = 57.8 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 5Penguin Solutions, Inc.PENG | 57.7/100Mixed-positive evidence67% evidence | LEADER | 24.6/35 Revenue 12% · PAT — · OPM change 7.6 pp 71% evidence | 10.2/25 ROCE 4.2% · OPM 10.6% 76% evidence | 8.6/20 P/E 39.6× · PEG — 15% evidence | 14.3/20 RS sector 67% · RS bench 67.3% · 1Y 148.7%12 of 12 weeks ahead 100% evidence |
| Exact sum: 24.6 + 10.2 + 8.6 + 14.3 = 57.7 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 6Innodata Inc.INOD | 56.2/100Mixed-positive evidence81% evidence | FADING | 24.0/35 Revenue 40.1% · PAT 11.4% · OPM change 4.6 pp 83% evidence | 16.4/25 ROCE 14.9% · OPM 18.8% 76% evidence | 3.9/20 P/E 34.8× · PEG 5.17 65% evidence | 11.9/20 RS sector 5.5% · RS bench 3.2% · 1Y 61.3%11 of 12 weeks ahead 100% evidence |
| Exact sum: 24 + 16.4 + 3.9 + 11.9 = 56.2 · Decision use: Confirmed research leader: earnings, capital efficiency and relative strength agree. Move to management, catalyst and risk diligence. | ||||||
| 7ExlService Holdings, Inc.EXLS | 55.3/100Thin evidence · provisional58% evidence | TURNING | 19.2/35 Revenue — · PAT — · OPM change 0.4 pp 45% evidence | 15.9/25 ROCE 7% · OPM 16.1% 76% evidence | 9.9/20 P/E 16.3× · PEG — 15% evidence | 10.3/20 RS sector -11.1% · RS bench -13.9% · 1Y -18.5%1 of 12 weeks ahead 100% evidence |
| Exact sum: 19.2 + 15.9 + 9.9 + 10.3 = 55.3 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 8Ingram Micro Holding CorporationINGM | 53.6/100Thin evidence · provisional58% evidence | TURNING | 18.9/35 Revenue — · PAT — · OPM change 0 pp 45% evidence | 10.4/25 ROCE 3.1% · OPM 1.6% 76% evidence | 10.3/20 P/E 15× · PEG — 15% evidence | 14.0/20 RS sector 12.6% · RS bench 10.9% · 1Y 55.8%6 of 12 weeks ahead 100% evidence |
| Exact sum: 18.9 + 10.4 + 10.3 + 14 = 53.6 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 9CGI Inc.GIB | 51.2/100Thin evidence · provisional58% evidence | TURNING | 17.9/35 Revenue — · PAT — · OPM change 0.4 pp 45% evidence | 13.2/25 ROCE 4.3% · OPM 14.9% 76% evidence | 11.0/20 P/E 11.4× · PEG — 15% evidence | 9.1/20 RS sector -14.7% · RS bench -17.2% · 1Y -22.4%1 of 12 weeks ahead 100% evidence |
| Exact sum: 17.9 + 13.2 + 11 + 9.1 = 51.2 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 10Genpact LimitedG | 50.8/100Mixed-positive evidence81% evidence | TURNING | 15.1/35 Revenue 6.4% · PAT 8% · OPM change 0.2 pp 83% evidence | 14.2/25 ROCE 4.8% · OPM 15.3% 76% evidence | 13.1/20 P/E 11.4× · PEG 1.01 65% evidence | 8.4/20 RS sector -15.7% · RS bench -18.2% · 1Y -17.8%1 of 12 weeks ahead 100% evidence |
| Exact sum: 15.1 + 14.2 + 13.1 + 8.4 = 50.8 · Decision use: Cheap but unconfirmed: require improving earnings before treating the valuation as an opportunity. | ||||||
| 11ChronoScale Holdings CorporationCHRN | 50.0/100Mixed-positive evidence64% evidence | LEADER | 20.0/35 Revenue -164.9% · PAT — · OPM change 55.9 pp 62% evidence | 3.7/25 ROCE -112.9% · OPM -58.5% 76% evidence | 11.5/20 P/E 1× · PEG — 15% evidence | 14.8/20 RS sector 110.7% · RS bench 112.4% · 1Y 717.7%12 of 12 weeks ahead 100% evidence |
| Exact sum: 20 + 3.7 + 11.5 + 14.8 = 50 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 12Cognizant Technology Solutions CorporationCTSH | 48.8/100Thin evidence · provisional58% evidence | TURNING | 15.6/35 Revenue — · PAT — · OPM change -1.1 pp 45% evidence | 14.6/25 ROCE 5.1% · OPM 15.6% 76% evidence | 11.4/20 P/E 8.3× · PEG — 15% evidence | 7.2/20 RS sector -20.3% · RS bench -22.9% · 1Y -19.3%0 of 12 weeks ahead 100% evidence |
| Exact sum: 15.6 + 14.6 + 11.4 + 7.2 = 48.8 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 13CDW CorporationCDW | 46.9/100Mixed-negative evidence81% evidence | TURNING | 13.9/35 Revenue 7.4% · PAT -0.8% · OPM change -0.4 pp 83% evidence | 11.3/25 ROCE 4.2% · OPM 6.6% 76% evidence | 6.0/20 P/E 14.7× · PEG 4.79 65% evidence | 15.7/20 RS sector 2.2% · RS bench -0.3% · 1Y -5.5%1 of 12 weeks ahead 100% evidence |
| Exact sum: 13.9 + 11.3 + 6 + 15.7 = 46.9 · Decision use: Price leads the evidence: RS versus the benchmark is -0.3%, but earnings trajectory is weak. Wait for revenue and profit confirmation. | ||||||
| 14CACI International IncCACI | 45.9/100Mixed-negative evidence81% evidence | TURNING | 18.0/35 Revenue 9.6% · PAT 12.6% · OPM change 0.6 pp 83% evidence | 10.6/25 ROCE 2.6% · OPM 9.7% 76% evidence | 9.3/20 P/E 22.4× · PEG 1.56 65% evidence | 8.0/20 RS sector -11.3% · RS bench -13.4% · 1Y 5.9%0 of 12 weeks ahead 100% evidence |
| Exact sum: 18 + 10.6 + 9.3 + 8 = 45.9 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 15Leidos Holdings, Inc.LDOS | 44.5/100Mixed-negative evidence68% evidence | BASING | 13.5/35 Revenue — · PAT — · OPM change -1 pp 45% evidence | 12.1/25 ROCE 4.5% · OPM 11.5% 76% evidence | 14.5/20 P/E 14.5× · PEG 0.52 65% evidence | 4.4/20 RS sector -26.5% · RS bench -28.8% · 1Y -26%0 of 12 weeks ahead 100% evidence |
| Exact sum: 13.5 + 12.1 + 14.5 + 4.4 = 44.5 · Decision use: Cheap but unconfirmed: require improving earnings before treating the valuation as an opportunity. | ||||||
| 16Cipher Digital Inc.CIFR | 43.3/100Mixed-negative evidence64% evidence | FADING | 17.5/35 Revenue 38.8% · PAT — · OPM change -251.1 pp 62% evidence | 4.2/25 ROCE -3.9% · OPM -328.9% 76% evidence | 8.5/20 P/E 83× · PEG — 15% evidence | 13.1/20 RS sector 10% · RS bench 8.2% · 1Y 329.1%10 of 12 weeks ahead 100% evidence |
| Exact sum: 17.5 + 4.2 + 8.5 + 13.1 = 43.3 · Decision use: Price leads the evidence: RS versus the benchmark is 8.2%, but earnings trajectory is weak. Wait for revenue and profit confirmation. | ||||||
| 17EPAM Systems, Inc.EPAM | 41.9/100Mixed-negative evidence81% evidence | TURNING | 18.6/35 Revenue 14.2% · PAT -5.8% · OPM change 0.7 pp 83% evidence | 10.8/25 ROCE 3% · OPM 8.3% 76% evidence | 6.4/20 P/E 19.4× · PEG 2.74 65% evidence | 6.1/20 RS sector -29.6% · RS bench -32.2% · 1Y -29.1%1 of 12 weeks ahead 100% evidence |
| Exact sum: 18.6 + 10.8 + 6.4 + 6.1 = 41.9 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 18International Business Machines Corporationthis pageIBM | 40.3/100Thin evidence · provisional58% evidence | ASLEEP | 16.4/35 Revenue — · PAT — · OPM change 0.6 pp 45% evidence | 9.8/25 ROCE 2.6% · OPM 11.7% 76% evidence | 9.0/20 P/E 25× · PEG — 15% evidence | 5.1/20 RS sector -19.4% · RS bench -21.5% · 1Y -2.9%2 of 12 weeks ahead 100% evidence |
| Exact sum: 16.4 + 9.8 + 9 + 5.1 = 40.3 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 19Fidelity National Information Services, Inc.FIS | 39.8/100Mixed-negative evidence71% evidence | BASING | 12.7/35 Revenue 12.3% · PAT -257.8% · OPM change -0.9 pp 83% evidence | 9.4/25 ROCE 1.4% · OPM 12.8% 76% evidence | 11.2/20 P/E 9.1× · PEG — 15% evidence | 6.5/20 RS sector -25.9% · RS bench -28.3% · 1Y -37.8%0 of 12 weeks ahead 100% evidence |
| Exact sum: 12.7 + 9.4 + 11.2 + 6.5 = 39.8 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 20Keel Infrastructure Corp.KEEL | 39.8/100Mixed-negative evidence64% evidence | FADING | 12.9/35 Revenue 51.6% · PAT — · OPM change -192.9 pp 62% evidence | 3.9/25 ROCE -11.6% · OPM -266% 76% evidence | 9.5/20 P/E 20.8× · PEG — 15% evidence | 13.5/20 RS sector 17.7% · RS bench 15.9% · 1Y 231.5%11 of 12 weeks ahead 100% evidence |
| Exact sum: 12.9 + 3.9 + 9.5 + 13.5 = 39.8 · Decision use: Price leads the evidence: RS versus the benchmark is 15.9%, but earnings trajectory is weak. Wait for revenue and profit confirmation. | ||||||
| 21Pony AI Inc.PONY | 39.8/100Mixed-negative evidence61% evidence | BASING | 24.6/35 Revenue 41.6% · PAT — · OPM change 230.6 pp 62% evidence | 4.0/25 ROCE -4.5% · OPM -170.3% 76% evidence | 10.0/20 P/E — · PEG — 0% evidence | 1.2/20 RS sector -42.4% · RS bench -44.7% · 1Y -45.4%0 of 12 weeks ahead 100% evidence |
| Exact sum: 24.6 + 4 + 10 + 1.2 = 39.8 · Decision use: Acceleration candidate, not a confirmed leader: earnings are strong but sector-relative strength is -42.4% and the one-year return is -45.4%. Do not upgrade until sector-relative strength is above zero and another reported period confirms growth. | ||||||
| 22Accenture plcACN | 39.2/100Mixed-negative evidence85% evidence | BASING | 12.2/35 Revenue 6.7% · PAT -2% · OPM change 0.2 pp 95% evidence | 15.8/25 ROCE 6.9% · OPM 17% 76% evidence | 6.3/20 P/E 14.9× · PEG 3.4 65% evidence | 4.9/20 RS sector -27.5% · RS bench -29.9% · 1Y -28.7%0 of 12 weeks ahead 100% evidence |
| Exact sum: 12.2 + 15.8 + 6.3 + 4.9 = 39.2 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 23Applied Digital CorporationAPLD | 37.6/100Thin evidence · provisional55% evidence | FADING | 16.7/35 Revenue — · PAT — · OPM change -31.8 pp 45% evidence | 4.5/25 ROCE -2.5% · OPM -67.6% 76% evidence | 10.0/20 P/E — · PEG — 0% evidence | 6.4/20 RS sector -4.6% · RS bench -6.4% · 1Y 120.2%8 of 12 weeks ahead 100% evidence |
| Exact sum: 16.7 + 4.5 + 10 + 6.4 = 37.6 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 24Kyndryl Holdings, Inc.KD | 35.2/100Mixed-negative evidence71% evidence | TURNING | 11.9/35 Revenue 0.2% · PAT -21.4% · OPM change 0.6 pp 83% evidence | 7.1/25 ROCE 2.6% · OPM 4.3% 76% evidence | 10.2/20 P/E 15.4× · PEG — 15% evidence | 6.0/20 RS sector -32.4% · RS bench -35.3% · 1Y -52.1%1 of 12 weeks ahead 100% evidence |
| Exact sum: 11.9 + 7.1 + 10.2 + 6 = 35.2 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 25Parsons CorporationPSN | 34.8/100Thin evidence · provisional58% evidence | BASING | 13.9/35 Revenue — · PAT — · OPM change -0.6 pp 45% evidence | 9.0/25 ROCE 0.1% · OPM 6.4% 76% evidence | 8.8/20 P/E 36.1× · PEG — 15% evidence | 3.1/20 RS sector -32.2% · RS bench -34.2% · 1Y -37.4%1 of 12 weeks ahead 100% evidence |
| Exact sum: 13.9 + 9 + 8.8 + 3.1 = 34.8 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 26Wise Group plcWSE | 43.6/100Thin evidence · provisional49% evidence | ASLEEP | 16.2/35 Revenue — · PAT — · OPM change -7.3 pp 19% evidence | 11.7/25 ROCE 0% · OPM 30.1% 76% evidence | 9.2/20 P/E 24.6× · PEG — 15% evidence | 6.5/20 RS sector -10.7% · RS bench -12.5% · 1Y -10.4%0 of 12 weeks ahead 100% evidence |
| Exact sum: 16.2 + 11.7 + 9.2 + 6.5 = 43.6 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 27NIQ Global Intelligence plcNIQ | 37.5/100Thin evidence · provisional47% evidence | TURNING | 16.1/35 Revenue — · PAT — · OPM change -2.6 pp 39% evidence | 4.9/25 ROCE -0.4% · OPM -1% 76% evidence | 10.0/20 P/E — · PEG — 0% evidence | 6.5/20 RS sector -17.6% · RS bench -20.3% · 1Y -34.8%0 of 12 weeks ahead 70% evidence |
| Exact sum: 16.1 + 4.9 + 10 + 6.5 = 37.5 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
Missing observations are not scored as bad. Their missing weight lowers confidence and pulls the final score toward neutral. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led S&P 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step curve the sector itself is placed on — basing, turning, breaking out, leader, fading, asleep — read from how many weeks running it has led S&P 500 and whether that lead is widening or shrinking. It describes where the PRICE stands, not the earnings trajectory and not a recommendation, and it is left blank for a company whose weekly history is too short or too stale to read.
Frequently asked questions
What is International Business Machines Corporation's stock price today?
International Business Machines Corporation trades at $235, −6.0% over the past year. The company is valued at $222 B. The stock sits at 23% of its 52-week range of $213–$309, −12.9% versus its 200-day average. On the tape, the price is in a downtrend, 1 weeks in. — as of 5 August 2026.
What were International Business Machines Corporation's latest quarterly results?
International Business Machines Corporation reported revenue of $15.9 B and net profit of $1.2 B for the Mar 26 quarter. Revenue rose 9.5% and profit rose 16.2% year on year. Earnings per share were $1.28. The operating margin was 11.7%, 0.6 pp higher than a year earlier. — as of 5 August 2026.
What is International Business Machines Corporation's revenue?
International Business Machines Corporation reported revenue of $15.9 B in the Mar 26 quarter, +9.5% year on year. For the full FY25 fiscal year, revenue was $67.5 B (+7.6%). Over the last 4 years revenue compounded at 4.2% a year. — as of 5 August 2026.
What is International Business Machines Corporation's profit?
International Business Machines Corporation earned $1.2 B of net profit in the Mar 26 quarter, +16.2% year on year — the 2nd straight quarter of growth. Full-year FY25 profit was $10.6 B. The operating margin ran 11.7% in the latest quarter. — as of 5 August 2026.
What is International Business Machines Corporation's market cap?
International Business Machines Corporation's market capitalisation is $222 B at a stock price of $235. Market cap is the share price multiplied by shares outstanding, so it is restated whenever the price moves. — as of 5 August 2026.
What is International Business Machines Corporation's P/E ratio?
International Business Machines Corporation trades at a P/E of 20.1×, at the 10th percentile of its own 4-year range, against a long-run median of 31.7×. This is a comparison with the stock's own history, not a value call — as of 5 August 2026.
Does International Business Machines Corporation pay a dividend?
Yes — International Business Machines Corporation declared $1.68 per share for Mar 26, and $6.72 per share across the last four reported quarters. The latest quarter is up 0.6% on the same quarter a year earlier. — as of 5 August 2026.
What is International Business Machines Corporation's dividend per share?
International Business Machines Corporation's most recently declared dividend is $1.68 per share for Mar 26, giving $6.72 per share over the trailing twelve months. Each figure is the amount declared for that quarter as reported, added across four quarters for the trailing total. — as of 5 August 2026.
What is International Business Machines Corporation's dividend yield?
International Business Machines Corporation's trailing dividend yield is 2.86%: $6.72 declared per share across the last four reported quarters, against a share price of $235. Each quarter’s figure is the amount declared for that quarter as reported, added across four quarters and divided by the latest close. — as of 5 August 2026.
Is International Business Machines Corporation overvalued?
On its own history, International Business Machines Corporation looks cheap against its own history: its P/E of 20.1× has been cheaper only 10% of the time in 4 years (long-run median 31.7×). That is a percentile read against the stock's own past, not a price opinion or a direction call. One caveat: margins are the best this company has ever printed — cheap on record margins is not the same thing as cheap. — as of 5 August 2026.
Is International Business Machines Corporation growing?
Yes — International Business Machines Corporation is growing: latest-quarter revenue +9.5% year on year, profit +16.2%, and the margin +0.6 pp at 11.7%. The 4-year compound rates are 4.2% (revenue) and 22.4% (profit). The earnings engine currently reads: improving — as of 5 August 2026.
How is International Business Machines Corporation performing?
International Business Machines Corporation is in a downtrend, 1 weeks in. Its latest quarter's revenue rose 9.5% and profit rose 16.2% year on year. Against the S&P 500 it has been behind on a trailing-13-week view for 4 weeks. This describes what the data did, not a rating. — as of 5 August 2026.
What stage is International Business Machines Corporation in?
Mixed — the growth curves are steadily positive, but ROCE at 10.5% is below the 15% bar this page requires to call it Consistent. The read comes from the last 12 quarters of growth (revenue growth +9.7% latest, profit growth +95.4% latest, eps growth +94.0% latest) plus the ROCE curve, classified by deterministic rules — a trajectory read, not a buy or sell call — as of 5 August 2026.
Is International Business Machines Corporation in an uptrend?
No — the price is in a downtrend (week 1 of stage 4), trading −12.9% versus its 200-day average and at 23% of its 52-week range. Price stages cycle base → advance → top → decline, and the stage names where this stock sits in that cycle — as of 5 August 2026.
Is International Business Machines Corporation beating the market?
Not lately — on a trailing-13-week view International Business Machines Corporation is currently behind the S&P 500 (4 weeks and counting; last ahead the week of 2026-07-10), the same metric the week-by-week ribbon on this page draws. Separately, on the cumulative view: over the last 10.1 years the stock moved +59% against the S&P 500's +263% — behind the index over the full window. — as of 5 August 2026.
Will International Business Machines Corporation's stock price go up?
This page publishes no price forecast for International Business Machines Corporation. What it measures instead: the stock price is $235, the price is in a downtrend 1 weeks in. Its P/E of 20.1× sits at the 10th percentile of its own 4-year range. — as of 5 August 2026.
Is the market betting against International Business Machines Corporation?
Somewhat — short interest is 3.5% of International Business Machines Corporation's tradable float, about 2.8 days to cover at typical volumes. A moderate reading: some money is positioned against it. With no quarter-by-quarter holder register here, short interest is the cleanest crowd read we hold — as of 5 August 2026.
Does International Business Machines Corporation have too much debt?
It carries real leverage — International Business Machines Corporation's debt-to-equity is 1.89. A year-by-year borrowings ladder is not in our numbers for this stock, so the latest reading is the cleanest hold. Read the returns on this page with that leverage in mind — as of 5 August 2026.
What is International Business Machines Corporation's capex?
International Business Machines Corporation spent $3.0 B on capital expenditure over the last 3 fiscal years, a figure derived from the change in fixed assets plus depreciation. In FY25 alone that was $1.1 B. — as of 5 August 2026.
What is International Business Machines Corporation's cash flow?
International Business Machines Corporation generated $13.2 B of operating cash flow in FY25 and $12.1 B of free cash flow after $1.1 B of capital spending. Reported profit that year was $10.6 B, so operating cash ran ahead of profit. — as of 5 August 2026.
Is International Business Machines Corporation's profit real cash?
Yes — over the last 3 fiscal years, 168% of International Business Machines Corporation's reported profit arrived as operating cash. In FY25, operating cash was $13.2 B against reported profit of $10.6 B. The cash then goes mostly into building capacity. Cash-flow resolution is annual — as of 5 August 2026.
How financially safe is International Business Machines Corporation?
On the balance sheet, the Z-score reads 3.40 — above roughly 3 is safe, below roughly 1.8 is the distress zone. That sits well clear of trouble. — as of 5 August 2026.
Where is International Business Machines Corporation in its business cycle?
International Business Machines Corporation's FY25 operating margin was 18.2%, against a 5-year band of 3.9%–18.2%: the top of the band — a record year. Record profitability is late-cycle territory: every ratio flatters at the top, and the story leans on margins holding. The latest quarter ran 11.7%. Profitability versus a company's own long band is the cleanest cycle clock this page holds — as of 5 August 2026.
What could break the International Business Machines Corporation story?
The sharpest disagreement: annual EPS moved +73.7% against a −6.0% price move — the market has not yet caught up with the delivery. Mechanically, two Friday closes in a row below the 200-day average would end the price trend — that is the exit rule this page tracks — as of 5 August 2026.
Is International Business Machines Corporation a stock worth studying right now?
This is not investment advice. The machine read: International Business Machines Corporation's earnings have outrun its stock. EPS grew +73.7% in a year against a −6.0% price move. The sharpest open question: whether the price catches up with earnings that have already moved. Every number on this page is drawn deterministically from the raw series, with no forecasts and no price opinions — as of 5 August 2026.